Form 8-K - Current report:
SEC Accession No. 0001193125-22-061322
Filing Date
2022-03-01
Accepted
2022-03-01 16:11:19
Documents
14
Period of Report
2022-03-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d299239d8k.htm   iXBRL 8-K 26189
2 EX-99.1 d299239dex991.htm EX-99.1 12025
6 GRAPHIC g299239g0301220751633.jpg GRAPHIC 3729
  Complete submission text file 0001193125-22-061322.txt   167370

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lnth-20220301.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20220301_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20220301_pre.xml EX-101.PRE 10814
8 EXTRACTED XBRL INSTANCE DOCUMENT d299239d8k_htm.xml XML 3240
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 22698090
SIC: 2835 In Vitro & In Vivo Diagnostic Substances